86 related articles for article (PubMed ID: 10069259)
1. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer.
Schuurman AG; Zeegers MP; Goldbohm RA; van den Brandt PA
Epidemiology; 1999 Mar; 10(2):192-5. PubMed ID: 10069259
[TBL] [Abstract][Full Text] [Related]
2. Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study.
Schuurman AG; van den Brandt PA; Dorant E; Goldbohm RA
Br J Cancer; 1999 Jun; 80(7):1107-13. PubMed ID: 10362125
[TBL] [Abstract][Full Text] [Related]
3. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.
van den Brandt PA; Zeegers MP; Bode P; Goldbohm RA
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):866-71. PubMed ID: 14504196
[TBL] [Abstract][Full Text] [Related]
4. Physical activity and the risk of prostate cancer in the Netherlands cohort study, results after 9.3 years of follow-up.
Zeegers MP; Dirx MJ; van den Brandt PA
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1490-5. PubMed ID: 15941961
[TBL] [Abstract][Full Text] [Related]
5. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
6. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of physical activity and incident and fatal prostate cancer.
Giovannucci EL; Liu Y; Leitzmann MF; Stampfer MJ; Willett WC
Arch Intern Med; 2005 May; 165(9):1005-10. PubMed ID: 15883238
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of cruciferous vegetables and prostate cancer.
Giovannucci E; Rimm EB; Liu Y; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1403-9. PubMed ID: 14693729
[TBL] [Abstract][Full Text] [Related]
9. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study.
Platz EA; Leitzmann MF; Michaud DS; Willett WC; Giovannucci E
Cancer Res; 2003 Dec; 63(23):8542-8. PubMed ID: 14679023
[TBL] [Abstract][Full Text] [Related]
10. Aspirin use in relation to risk of prostate cancer.
Leitzmann MF; Stampfer MJ; Ma J; Chan JM; Colditz GA; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1108-11. PubMed ID: 12376516
[TBL] [Abstract][Full Text] [Related]
11. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
12. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.
Kurahashi N; Iwasaki M; Sasazuki S; Otani T; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):538-45. PubMed ID: 17337648
[TBL] [Abstract][Full Text] [Related]
13. Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.
Schuurman AG; van den Brandt PA; Dorant E; Brants HA; Goldbohm RA
Cancer; 1999 Sep; 86(6):1019-27. PubMed ID: 10491529
[TBL] [Abstract][Full Text] [Related]
14. Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men.
Larsson SC; Akesson A; Wolk A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1939-41. PubMed ID: 19505926
[TBL] [Abstract][Full Text] [Related]
15. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
Grönberg H; Wiklund F; Damber JE
Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
[TBL] [Abstract][Full Text] [Related]
16. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
Zeegers MP; Jellema A; Ostrer H
Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
[TBL] [Abstract][Full Text] [Related]
17. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
18. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.
Hawk E; Breslow RA; Graubard BI
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):523-7. PubMed ID: 10815699
[TBL] [Abstract][Full Text] [Related]
19. Familial aspects of prostate cancer: a case control study.
Keetch DW; Rice JP; Suarez BK; Catalona WJ
J Urol; 1995 Dec; 154(6):2100-2. PubMed ID: 7500468
[TBL] [Abstract][Full Text] [Related]
20. Height-related risk factors for prostate cancer.
Norrish AE; McRae CU; Holdaway IM; Jackson RT
Br J Cancer; 2000 Jan; 82(1):241-5. PubMed ID: 10638996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
